ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

This adverse event was reported 2583 times

These drugs are most commonly taken by patients reporting ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE:

# Drug Count
0 METHOTREXATE SODIUM 2463
1 LEFLUNOMIDE 2386
2 ADALIMUMAB 2372
3 METHOTREXATE 2365
4 ETANERCEPT 2329
5 TOCILIZUMAB 2276
6 INFLIXIMAB 2265
7 CERTOLIZUMAB PEGOL 2224
8 ABATACEPT 2159
9 HYDROXYCHLOROQUINE SULFATE 2156
See all common drugs associated with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE 129 0.5331
1 PSEUDOEPHEDRINE HCL 1371 0.3084
2 CORTISONE ACETATE 1468 0.2601
3 CAFFEINE CITRATE 210 0.2564
4 CHLORHEXIDINE GLUCONANTE 1 0.2500
5 DESOXIMETASONE 1979 0.2396
6 CHLORHEXIDINE GLUCONATE AND ISOPROPYL ALCOHOL 24 0.1455
7 PSEUDOEPHEDRINE HYDROCHLORIDE 1322 0.1306
8 SARILUMAB 1068 0.1180
9 CETIRIZINE HYDROCHLORIDE TABLETS 1477 0.1144
See all drugs enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE

ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antirheumatic Agent [EPC] 2386 0.0302
1 Interleukin-6 Receptor Antagonist [EPC] 2301 0.0290
2 Aminosalicylate [EPC] 2144 0.0243
3 Selective T Cell Costimulation Modulator [EPC] 2159 0.0232
4 Standardized Chemical Allergen [EPC] 224 0.0194
5 Histamine-1 Receptor Antagonist [EPC] 608 0.0190
6 Interleukin-12 Antagonist [EPC] 1070 0.0165
7 Interleukin-23 Antagonist [EPC] 1070 0.0142
8 CD20-directed Cytolytic Antibody [EPC] 2072 0.0124
9 Vitamin D [EPC] 2077 0.0110
See all drug classes enriched for association with ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE